Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers

Journal of Hypertension

Volumn 27, Issue 11, 2009, Pages 2257-2264

  Hamad, Rangeen Rafik ^a   Larsson, Anders ^b   Pernow, John ^c   Bremme, Katarina ^a   Eriksson, Maria J ^d  

^a Karolinska Lnstitutet   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Department of Cardiology ^*  (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amlno termlnal pro brain natriuretic peptide; Biomarkers; C reactive protein; Cystatin c; Echocardiography; Follow up; Left ventricular diastolic function; Preeclampsia; Pregnancy; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYSTATIN C; TROPONIN I;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 73249144294     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283300541     Document Type: Article

References (44)

1. Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB. Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function. Ultrasound Obstet Gynecol 2007; 29:414-420. (Pubitemid 46632237)
2. Hibbard JU, Shroff SG, Lang RM. Cardiovascular changes in preeclampsia. Semin Nephrol 2004; 24:580-587.
3. Novelli GP, Valensise H, Vasapollo B, Larciprete G, Di Pierro G, Altomare F, Arduini D. Are gestational and essential hypertension similar? Left ventricular geometry and diastolic function. Hypertens Pregnancy 2003; 22:225-237. (Pubitemid 37288686)
4. Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 2002; 283:H1627-H1633.
5. Atkins AF, Watt JM, Milan P, Davies P, Crawford JS. A longitudinal study of cardiovascular dynamic changes throughout pregnancy. Eur J Obstet Gynecol Reprod Biol 1981; 12:215-224. (Pubitemid 11022340)
6. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68:540-543.
7. Hirota Y. A clinical study of left ventricular relaxation. Circulation 1980; 62:756-763. (Pubitemid 10009691)
8. Yamamoto K, Redfield MM, Nishimura RA. Analysis of left ventricular diastolic function. Heart 1996; 75 (6 Suppl 2):27-35. (Pubitemid 26183700)
9. Fok WY, Chan LY, Wong JT, Yu CM, Lau TK Left ventricular diastolic function during normal pregnancy: assessment by spectral tissue Doppler imaging. Ultrasound Obstet Gynecol 2006; 28:789-793. (Pubitemid 44787464)
10. Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruc N. The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy. J Perinat Med 2005; 33:121-124. (Pubitemid 40477071)
11. Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, Maisel A. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol 2005; 193:450-454. (Pubitemid 41159541)
12. Borghi C, Esposti DD, lmmordino V, Cassani A, Boschi S, Bovicelli L, Ambrosioni E. Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. Am J Obstet Gynecol 2000;183:140-147.
13. Lx JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA. Cystatin C, left ventricular hypertrophy and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail 2006; 12:601-607.
14. Jemberg T, Lindahl B, James S, Larsson A, Hansson LO, Walentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004; 110:2342-2348. (Pubitemid 39407337)
15. Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 2001 ; 61:575-580. (Pubitemid 33702365)
16. Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, Larsen S. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and preeclamptic pregnancies. BJOG 2003; 110:825-830. (Pubitemid 37159267)
17. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107-2116. (Pubitemid 351679597)
18. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Peeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. BMJ 2007; 335:974.
19. Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert Rev Cardiovasc Ther 2007; 5:283-294.
20. Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007; 109:1368-1374. (Pubitemid 46869876)
21. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset preeclampsia with and without fetal growth restriction. BJOG 2006; 113:580-589.
22. Sibai BM. Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension 2008; 52:805-806.
23. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892-898. (Pubitemid 18106884)
24. Stepan H, Unversucht A, Wessel N, Faber R. Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49:818-824. (Pubitemid 351664216)
25. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083. (Pubitemid 9091990)
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458. (Pubitemid 16119719)
27. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20:1251-1260.
28. Rodin M, Jonsson AS, Hansson LO, Danielsson LA, Larsson A. Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L Scand J Clin Lab Invest 2007; 67:560-567. (Pubitemid 47344352)
29. Lang RM, Pridjian G, Feldman T, Neumann A, Lindheimer M, Borow KM. Left ventricular mechanics in preeclampsia Am Heart J 1991 ; 121 (6 Pt 1): 1768-1775.
30. Valensise H, Vasapollo B, Novelli GP, Pasqualetti P, Galante A, Arduini D. Maternal total vascular resistance and concentric geometry: a key to identify uncomplicated gestational hypertension. BJOG 2006; 113:1044-1052. (Pubitemid 44310097)
31. lngec M, Yilmaz M, Gundogdu F. Left atrial mechanical functions in preeclampsia. J Obstet Gynaecol Res 2005; 31:535-539.
32. Ceyhan C, Unal S, Yenisey C, Tekten T, Ceyhan FB. The role of N terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients, lnt J Cardiovasc Imaging 2008; 24:253-259.
33. Lee SW, Park MC, Park YB, Lee SK. E/E' rate is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus. Lupus 2008; 17:195-201.
34. Bamfo JE, Kametas NA, Chambers JB, Nicolaides KH. Maternal cardiac function in normotensive and preeclamptic intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32:682-686.
35. Tihtonen KM, Koobi T, Vuofteenaho O, Huhlala HS, Uotila JT. Natriuretic peptides and hemodynamics in preeclampsia. Am J Obstet Gynecol 2007; 196:328 e1 -328 e7.
36. Yoshimura T, Yoshimura M, Yasue H, lto M, Okamura H, Mukoyama M, Nakao K. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 1994; 140:393-397. (Pubitemid 24117205)
37. Moran A, Katz R, Smith NL, Fried LF, Sarnak MJ, Seliger SL, Psaty B. Cystatin C concentration as a predictor of systolic and diastolic heart failure. J Card Fail 2008; 14:19-26.
38. Kristensen K, Wide-Swensson D, Schmidt C, Blirup-Jensen S, Lindstrom V, Strevens H, Grubb A. Cystatin C, beta-2-microglobulin and beta-trace protein in preeclampsia. Acta Obstet Gynecol Scand 2007; 86:921-926.
39. Ammann P, Pfisterer M, Fehr T, Rickli H. Raised cardiac troponins. BMJ 2004; 328:1028-1029.
40. Eggers KM, Dellborg M, Oldgren J, Swahn E, Venge P, Lindahl B. Risk prediction in chest pain patients by biochemical markers including estimates of renal function, lnt J Cardiol 2008; 128:207-213. (Pubitemid 352033580)
41. Joyal D, Leya F, Koh M, Besinger R, Ramana R, Kahn S, Jeske W. Troponin I levels in patients with preeclampsia. Am J Med 2007; 120:819 e13-819 e14.
42. Fleming SM, O'Gorman T, Finn J, Grimes H, Daly K, Morrison JJ. Cardiac troponin I in preeclampsia and gestational hypertension. BJOG 2000; 107:1417-1420.
43. Paternoster DM, Fantinato S, Stella A, Nanhomgue KN, Milani M, Plebani M, Nicolini U. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost 2006; 12:330-337. (Pubitemid 44400845)
44. Larsson A, Palm M, Hansson LO, Basu S, Axelsson O. Reference values for alpha1-acid glycoprotein, alpha1 -antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy. Acta Obstet Gynecol Scand 2008; 87:1084-1088.